Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathogenesis and Therapeutic Strategies Related to Non-Alcoholic Fatty Liver Disease
Tieshan Teng, Shuai Qiu, Yiming Zhao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7841-7841
Open Access | Times Cited: 19

Showing 19 citing articles:

Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications
Ziwei Guo, Qinjuan Wu, Pengfei Xie, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Red Rice Bran Extract Alleviates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease and Dyslipidemia in Mice
Narongsuk Munkong, Surasawadee Somnuk, Nattanida Jantarach, et al.
Nutrients (2023) Vol. 15, Iss. 1, pp. 246-246
Open Access | Times Cited: 14
Fanlian Huazhuo Formula alleviates high-fat diet-induced non-alcoholic fatty liver disease by modulating autophagy and lipid synthesis signaling pathway
Mengyuan Niu, Gengting Dong, Yi Li, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 30, pp. 3584-3608
Closed Access | Times Cited: 5
Natural Product Skatole Ameliorates Lipotoxicity-Induced Multiple Hepatic Damage under Hyperlipidemic Conditions in Hepatocytes
Sin‐Hyoung Hong, Yeonhee Hong, Minji Lee, et al.
Nutrients (2023) Vol. 15, Iss. 6, pp. 1490-1490
Open Access | Times Cited: 12
Unlocking the therapeutic potential of canagliflozin in NAFLD: Insights into AMPK/SIRT1-mediated lipophagy
Nahla E. El‐Ashmawy, Ghada M. Al‐Ashmawy, Asmaa A. Kamel, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 3, pp. 167666-167666
Closed Access
Feasibility of Serum Galectin-1 as a Diagnostic Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study on a Segment of the Chinese Population Using Convenience Sampling
Ting Zeng, Fang Li, Min Jae Yang, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 425-425
Open Access
Особливості стоматологічного статусу хворих при різних патогенетичних формах неалкогольної жирової хвороби печінки
D. V. Еmelyanov
Likarska sprava (2025), Iss. 1
Open Access
Curcumin protects against bisphenol A‐induced hepatic steatosis by inhibiting cholesterol absorption and synthesis in CD‐1 mice
Ting Hong, Jun Zou, Jie Yang, et al.
Food Science & Nutrition (2023) Vol. 11, Iss. 9, pp. 5091-5101
Open Access | Times Cited: 9
To do one and to get more: Part II. Diabetes and metabolic dysfunction-associated fatty liver diseases
Wen-Ling Lee, Peng‐Hui Wang, Szu‐Ting Yang, et al.
Journal of the Chinese Medical Association (2022)
Open Access | Times Cited: 14
Effects of Folic Acid Supplementation on Liver Enzymes, Lipid Profile, and Insulin Resistance in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial
Mohamad Reza Molaqanbari, Shadi Zarringol, Hamid Reza Talari, et al.
Advanced Biomedical Research (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Neutral Sphingomyelinase 2 Inhibition Limits Hepatic Steatosis and Inflammation
Fatema Al‐Rashed, Hossein Arefanian, Ashraf Al Madhoun, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 463-463
Open Access | Times Cited: 1
Emerging Insights into the Role of BDNF on Health and Disease in Periphery
Mayuko Ichimura‐Shimizu, Khuleshwari Kurrey, Misaki Miyata, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 444-444
Open Access | Times Cited: 1
Tocotrienol in the Management of Nonalcoholic Fatty Liver Disease: A Systematic Review
Kok‐Yong Chin, Sophia Ogechi Ekeuku, Deborah Chia Hsin Chew, et al.
Nutrients (2023) Vol. 15, Iss. 4, pp. 834-834
Open Access | Times Cited: 3
Recent insights into the pathogenesis and therapeutic targets of chronic liver diseases
Yankai Wen, Lichun Ma, Cynthia Ju
eGastroenterology (2023) Vol. 1, Iss. 2, pp. e100020-e100020
Open Access | Times Cited: 3
Effects of Monacolin K in Nondiabetic Patients with NAFLD: A Pilot Study
Andrea Da Porto, Debora Donnini, Fabio Vanin, et al.
Nutrients (2023) Vol. 15, Iss. 8, pp. 1887-1887
Open Access | Times Cited: 2
Glucocorticoid receptor modulator CORT125385 alleviates diet-induced hepatosteatosis in male and female mice
Jan Kroon, Max Gentenaar, Tijmen J.A. Moll, et al.
European Journal of Pharmacology (2023) Vol. 957, pp. 176012-176012
Open Access | Times Cited: 2
NAFLD/MAFLD: New Evidence
Alessandro Mantovani, Andrea Dalbeni
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7241-7241
Open Access | Times Cited: 1
Neutral Sphingomyelinase 2 Inhibition Limits Hepatic Steato-sis and Inflammation
Fatema Al‐Rashed, Hossein Arefanian, Ashraf Al Madhoun, et al.
(2023)
Open Access | Times Cited: 1
Investigation of the Antihyperlipidemic Mechanism of Potential Probiotics
Fatma Salem, Mohamed M. Aboulwafa, Shahenda Mahgoub, et al.
Journal of Advanced Pharmacy Research (2023) Vol. 7, Iss. 2, pp. 120-126
Open Access
NAFLD and AATD Are Two Diseases with Unbalanced Lipid Metabolism: Similarities and Differences
Sara Pérez-Luz, Nerea Matamala, Gema Gómez‐Mariano, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1961-1961
Open Access
Page 1

Scroll to top